An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali

Trial Profile

An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2015

At a glance

  • Drugs Bovine rotavirus vaccine reassortant (Primary) ; Measles vaccines; Meningococcal vaccine conjugate; Yellow fever vaccine
  • Indications Rotavirus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Aug 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 31 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 30 Dec 2014 Planned End Date changed from 1 Mar 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top